ALK and lung cancer: Anaplastic lymphoma kinase (ALK) is a transmembrane tyrosine kinase receptor that is frequently rearranged, mutated or amplified in specific neoplastic diseases, including lymphoma, neuroblastoma, lung cancer and, albeit to a lesser extent, melanoma [25].